Research conducted in the Surgical Oncology laboratories includes novel therapeutic approaches to liver cancer, immunological therapies for melanoma, as well as genetically driven approaches to the treatment of breast, gastrointestinal and head and neck cancers.
Our Surgical Oncology Investigators are:
- Kenneth K. Tanabe, MD
Chief, Division of Surgical Oncology
- James C. Cusack, Jr., MD
Director of Surgical Oncology Research
- Shyamala Maheswaran, PhD
- James W. Rocco, MD, PhD
- Jennifer A. Wargo, MD
About Cancer Research at the Massachusetts General Hospital Cancer Center
Massachusetts General Hospital was established in 1811 and is the original and largest teaching hospital of Harvard Medical School. With an annual budget of more than $500 million, it conducts the largest hospital-based research program in the United States, through major research centers in cancer, human genetics, regenerative biology, systems biology, AIDS, cardiovascular medicine, computational biology, cutaneous biology, transplantation biology and photomedicine.
Research on cancer -- ranging from studies of genetic and epigenetic causes to sophisticated imaging, molecular therapeutics, bioengineering and computational biology, and population-based prevention studies -- takes place across the entire institution: in the dedicated laboratories of the Center for Cancer Research, the Steele Laboratory within the department of radiation oncology, and in laboratories within the departments of medicine, surgery, radiation therapy, pediatrics, pathology, radiology, neurology, neurosurgery, molecular biology, orthopedics, urology, dermatology and psychiatry. Clinical research is orchestrated within dedicated multidisciplinary disease centers and supported by a centralized protocol office. Massachusetts General is proud of its exceptionally diverse and collaborative research program on cancer, spanning from the laboratory to the clinic.